Publication | Open Access
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
197
Citations
28
References
2014
Year
UrologyMedicineCancer ManagementPathologyTumour Marker DeclineCancer TreatmentOncologyRadiation OncologyGetug 13Cancer ResearchPhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1